Cencora, Inc. logo
Cencora, Inc. (COR)
Compare

Cencora, Inc. (COR) Current Ratio: 0.90

Is Cencora, Inc.’s current ratio high or low?

Cencora, Inc.'s current ratio of 0.90 is in line with its 5-year average of 0.92, near the low end of its 5-year range (0.88–0.98).

As of Thursday, June 18, 2026. 1.12% above its 12-month average of 0.89.

COR Current Ratio Chart

COR Current Ratio
0.90+2.27% 1Y
Zoom

COR Average Current Ratio Chart

COR Current vs Average Current Ratio Chart

COR Current Ratio Metrics

CURRENT RATIO

0.90

CURRENT RATIO AVG TTM

0.89

CURRENT RATIO AVG 3Y

0.89

CURRENT RATIO AVG 5Y

0.92

CURRENT RATIO AVG 10Y

0.92

CURRENT RATIO AVG 15Y

0.94

CURRENT RATIO AVG 20Y

0.98

CURRENT VS TTM AVG

+1.12%

CURRENT VS 3Y AVG

+0.84%

CURRENT VS 5Y AVG

-1.64%

CURRENT VS 10Y AVG

-1.79%

CURRENT VS 15Y AVG

-4.70%

CURRENT VS 20Y AVG

-7.98%

COR Competitors' Current Ratio

NAMEMARKET CAPCURRENT RATIOTTM3Y5Y
Cencora, Inc. (COR)$53.91B0.900.890.890.92
Cardinal Health, Inc. (CAH)vs ›$53.00B0.940.961.001.04
Becton, Dickinson and Company (BDX)vs ›$51.30B1.111.141.161.25
Regeneron Pharmaceuticals, Inc. (REGN)vs ›$62.63B4.134.434.904.47
Humana Inc. (HUM)vs ›$43.46B0.720.580.570.58
IDEXX Laboratories, Inc. (IDXX)vs ›$43.08B1.171.241.231.33
Boston Scientific Corporation (BSX)vs ›$67.35B1.621.351.381.47
Agilent Technologies, Inc. (A)vs ›$35.12B1.962.022.172.21
Cigna Corporation (CI)vs ›$75.42B0.850.840.800.80
Zoetis Inc. (ZTS)vs ›$32.39B3.032.392.632.90

Liquidity Analysis

Current Ratio

0.90

Quick Ratio

0.55

Cencora, Inc. Current Ratio Formula & Definition

Current Ratio = Current Assets / Current Liabilities

The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Cencora, Inc. Current Ratio FAQ

What is the current ratio for Cencora, Inc. (COR)?
The current ratio for COR stock is 0.90.
Is Cencora, Inc.'s current ratio high or low?
Cencora, Inc.'s current ratio of 0.90 is in line with its 5-year average of 0.92, near the low end of its 5-year range (0.88–0.98).
What is the TTM average current ratio for Cencora, Inc. (COR)?
The TTM average current ratio for COR stock is 0.89.
What is the 3Y average current ratio for Cencora, Inc. (COR)?
The 3Y average current ratio for COR stock is 0.89.
What is the 5Y average current ratio for Cencora, Inc. (COR)?
The 5Y average current ratio for COR stock is 0.92.
What is the 10Y average current ratio for Cencora, Inc. (COR)?
The 10Y average current ratio for COR stock is 0.92.
What is the 15Y average current ratio for Cencora, Inc. (COR)?
The 15Y average current ratio for COR stock is 0.94.
What is the 20Y average current ratio for Cencora, Inc. (COR)?
The 20Y average current ratio for COR stock is 0.98.

Cencora, Inc. Current Ratio History

DATECURRENT RATIO
2025-09-300.90
2024-09-300.88
2023-09-300.88
2022-09-300.91
2021-09-300.94
2020-09-300.98
2019-09-300.95
2018-09-300.93
2017-09-300.91
2016-09-300.90
2015-09-300.90
2014-09-300.97
2013-09-300.97
2012-09-300.98
2011-09-301.03
2010-09-301.08
2009-09-301.05
2008-09-301.06
2007-09-301.11
2006-09-301.23
2005-09-301.32
2004-09-301.36
2003-09-301.42
2002-09-301.37
2001-09-301.36
2000-09-301.32
1999-09-301.45
1998-09-301.40
1997-09-301.44
1996-09-301.42

About Cencora, Inc.

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

Conshohocken, PA
47,000 employees
Healthcare / Medical - Distribution
Sector
Healthcare
Industry
Medical - Distribution
CEO
Robert Mauch